Andreas Reinisch

15PUBLICATIONS
91CO-AUTHORS
Molecular targetsToxicology (incl. clinical toxicology)Gene and molecular therapyMedical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 02, 2026
Ultraprecision therapy for type 1 vs type 2 CALR+ MPN by dual epitope targeting that restores ruxolitinib sensitivity.

Chloe A L Thompson-Peach, Daniel Thomas, Mara Dottore

|Dec 15, 2025
Triazoles Versus Echinocandins for the First-Line Treatment of Invasive Pulmonary Aspergillosis: A Propensity Score-Weighted Multicenter Study.

Stefan Hatzl, Christina Geiger, Lisa Kriegl

|Oct 22, 2025
Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Sonja Wurm, Jennifer M Moritz, Verena Petzer

|Feb 03, 2025
Pulmonary Coinfection of <i>Pneumocystis jirovecii</i> and <i>Aspergillus</i> Species.

Stefan Hatzl, Christina Geiger, Lisa Kriegl

|Nov 11, 2024
Acute myeloid leukemia in the next-generation sequencing era : Real-world data from an Austrian tertiary cancer care center.

Sonja Wurm, Michael Waltersdorfer, Simone Loindl

|Sep 06, 2023
BRAF<sup>V600E</sup> promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis.

Tommaso Sconocchia, Johannes Foßelteder, Lisa Auinger

Pageof 3

Frequent Collaborators

5 joint publications

Armin Zebisch

5 joint publications

Albert Wölfler

5 joint publications

Heinz Sill

4 joint publications

Johannes Foßelteder